Atlantic Private Wealth »

Denali Therapeutics shares owned by Atlantic Private Wealth

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Atlantic Private Wealth from 13F filings

Historical chart of Atlantic Private Wealth investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Atlantic Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Atlantic Private Wealth

Quarter filed Position value Share count Share price at filing
2025-12-31 $165 10 16.50

More positions owned by Atlantic Private Wealth

Spdr S&p500 Etf Etf (SPY)
Vanguard Idx Fund Etf (VTI)
Vanguard Total Etf (VXUS)
iShares iBonds Dec 2034 Term Treasury ETF Etf (IBTP)
Vanguard Extended Etf (VXF)
iShares iBonds Dec 2026 Term Treasury ETF Etf (IBTG)
Vanguard World Etf (ESGV)
iShares iBonds Dec 2032 Term Treasury ETF Etf (IBTM)
Ishares Ibonds Dec 2027 Term T (IBTH)
iShares TR Esg Awr Etf (EAGG)
iShares TR Esg SCRND Etf (XVV)
iShares Trust Esg Etf (DMXF)
Vanguard Intl Equity Etf (VEU)
Select Sector SPDR Etf (XLE)
iShares S&P 500 Etf (IVV)

View all positions for Atlantic Private Wealth

Top funds holding Denali Therapeutics

Vanguard Group
BlackRock
Baillie Gifford & Co
T. Rowe Price Investment Management
FMR
State Street Corporation
Temasek Holdings
Norges Bank Investment Management
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Capital Research Global Investors
Alliancebernstein
Geode Capital Management
Holocene Advisors

View all funds holding Denali Therapeutics